Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
Clinical trial NCT02014051 · COMPLETED
Trial details
- NCT number
- NCT02014051
- Sponsor
- SymBio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.